These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9217241)

  • 1. Effect of the route of benzo[a]pyrene administration on sister chromatid exchange and DNA binding in bone marrow of mice differing with respect to cytochrome P450 1A1 induction.
    Brauze D; Wielgosz SM; Pawlak AL; Baer-Dubowska W
    Toxicol Lett; 1997 May; 91(3):211-7. PubMed ID: 9217241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ah locus-associated differences in induction of sister-chromatid exchanges and in DNA adducts by benzo[a]pyrene in mice.
    Wielgosz SM; Brauze D; Pawlak AL
    Mutat Res; 1991 Jan; 246(1):129-37. PubMed ID: 1846026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among benzo(a)pyrene metabolism, benzo(a)pyrene-diol-epoxide:DNA adduct formation, and sister chromatid exchanges in human lymphocytes from smokers and nonsmokers.
    Thompson CL; McCoy Z; Lambert JM; Andries MJ; Lucier GW
    Cancer Res; 1989 Dec; 49(23):6503-11. PubMed ID: 2510927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation and persistence of benzo[a]pyrene--DNA adducts in different tissues of C57BL/10 and DBA/2 mice.
    Brauze D; Mikstacka R; Baer-Dubowska W
    Carcinogenesis; 1991 Sep; 12(9):1607-11. PubMed ID: 1909937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
    Ginsberg GL; Atherholt TB
    Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzo[a]pyrene-DNA-adducts and monooxygenase activities in mice treated with benzo[a]pyrene, cigarette smoke or cigarette smoke condensate.
    Bjelogrlic N; Iscan M; Raunio H; Pelkonen O; Vähäkangas K
    Chem Biol Interact; 1989; 70(1-2):51-61. PubMed ID: 2786769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
    Shiizaki K; Kawanishi M; Yagi T
    Mutat Res; 2013 Jan; 750(1-2):77-85. PubMed ID: 23036853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The time-dependent increase in the binding of benzo[a]pyrene to DNA through (+)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide in primary rat hepatocyte cultures results from induction of cytochrome P450IA1 by benzo[a]pyrene treatment.
    Eberhart J; Coffing SL; Anderson JN; Marcus C; Kalogeris TJ; Baird WM; Park SS; Gelboin HV
    Carcinogenesis; 1992 Feb; 13(2):297-301. PubMed ID: 1740021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in biotransformation enzymes for benzo[a]pyrene and related levels of benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in Goeckerman therapy.
    Beranek M; Fiala Z; Kremlacek J; Andrys C; Hamakova K; Chmelarova M; Palicka V; Borska L
    Toxicol Lett; 2016 Jul; 255():47-51. PubMed ID: 27188524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in murine procarcinogen activation enzymes are not accompanied by parallel differences in procarcinogen-induced sister-chromatid exchange.
    Schreck RR; Paika IJ; Latt SA
    Mutat Res; 1982 May; 94(1):143-53. PubMed ID: 6285186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical visualization of DNA adducts in mouse tissues and human white blood cells following treatment with benzo[a]pyrene or its diol epoxide. A quantitative approach.
    van Schooten FJ; Hillebrand MJ; Scherer E; den Engelse L; Kriek E
    Carcinogenesis; 1991 Mar; 12(3):427-33. PubMed ID: 1901249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
    Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
    Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing roles of cytochrome P450 1A1/1B1 and aldo-keto reductase 1A1 in the metabolic activation of (+/-)-7,8-dihydroxy-7,8-dihydro-benzo[a]pyrene in human bronchoalveolar cell extracts.
    Jiang H; Shen YM; Quinn AM; Penning TM
    Chem Res Toxicol; 2005 Feb; 18(2):365-74. PubMed ID: 15720144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dosimetry of DNA adducts and sister chromatid exchanges in human lymphocytes treated with benzo[a]pyrene.
    Wiencke JK; McDowell ML; Bodell WJ
    Carcinogenesis; 1990 Sep; 11(9):1497-502. PubMed ID: 2401041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzo[a]pyrene-globin adducts detected by synchronous fluorescence spectrophotometry: method development and relation to lung DNA adducts in mice.
    Bjelogrlic N; Vähäkangas K
    Carcinogenesis; 1991 Dec; 12(12):2205-9. PubMed ID: 1747919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of chlorophyllin on the frequency of sister chromatid exchanges produced by benzo[a]pyrene in vivo.
    Madrigal-Bujaidar E; Velázquez-Guadarrama N; Díaz-Barriga S
    Mutat Res; 1997 Jan; 388(1):79-83. PubMed ID: 9025794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
    Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ
    Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment of mice with benzo[a]pyrene or parenteral administration of benzo[a]pyrene diol epoxide-DNA to rats results in faecal excretion of a putative benzo[a]pyrene diol epoxide-deoxyguanosine adduct.
    Tierney B; Martin CN; Garner RC
    Carcinogenesis; 1987 Sep; 8(9):1189-92. PubMed ID: 3113751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldo-keto reductase- and cytochrome P450-dependent formation of benzo[a]pyrene-derived DNA adducts in human bronchoalveolar cells.
    Ruan Q; Gelhaus SL; Penning TM; Harvey RG; Blair IA
    Chem Res Toxicol; 2007 Mar; 20(3):424-31. PubMed ID: 17295519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow toxicity induced by oral benzo[a]pyrene: protection resides at the level of the intestine and liver.
    Legraverend C; Harrison DE; Ruscetti FW; Nebert DW
    Toxicol Appl Pharmacol; 1983 Sep; 70(3):390-401. PubMed ID: 6314600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.